日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Cochrane risk of bias assessment tool 2 (RoB 2) versus the original RoB: A perspective on the pros and cons

Cochrane偏倚风险评估工具2(RoB 2)与原始RoB:优缺点分析

Nejadghaderi, Seyed Aria; Balibegloo, Maryam; Rezaei, Nima

SIRT2 inhibition protects against cardiac hypertrophy and ischemic injury

SIRT2 抑制可防止心脏肥大和缺血性损伤

Xiaoyan Yang #, Hsiang-Chun Chang #, Yuki Tatekoshi #, Amir Mahmoodzadeh, Maryam Balibegloo, Zeinab Najafi, Rongxue Wu, Chunlei Chen, Tatsuya Sato, Jason Shapiro, Hossein Ardehali

SIRT2 inhibition protects against cardiac hypertrophy and heart failure

SIRT2 抑制可防止心脏肥大和心力衰竭

Xiaoyan Yang, Hsiang-Chun Chang, Yuki Tatekoshi, Maryam Balibegloo, Rongxue Wu, Chunlei Chen, Tatsuya Sato, Jason Shapiro, Hossein Ardehali